Clincosm LogoSign in Get a demo

gastric cancer

Showing NaN - NaN of 78
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (AZD5863)

Recruiting
  • Gastric Cancer
  • +3 more
  • Jacksonville, Florida
  • +16 more
Aug 17, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Phoenix, Arizona
  • +119 more
Feb 1, 2023

Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,

Recruiting
  • Advanced Solid Tumor
  • +10 more
  • Boston, Massachusetts
  • +8 more
Jan 2, 2023

Oesophageal Squamous Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma Trial in Worldwide (THOR-707, Pembrolizumab,

Active, not recruiting
  • Oesophageal Squamous Cell Carcinoma
  • +4 more
  • Duarte, California
  • +39 more
Oct 31, 2022

Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma Trial in Duarte, Iowa City, New York

Recruiting
  • Advanced Solid Tumor
  • +13 more
  • Duarte, California
  • +3 more
Oct 25, 2022

Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

Recruiting
  • Solid Tumor
  • +11 more
  • TRK-950
  • +14 more
  • Scottsdale, Arizona
  • +13 more
Oct 2, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • Duarte, California
  • +87 more
Aug 19, 2022

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (Pembrolizumab, Placebo, Cisplatin)

Active, not recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Pembrolizumab
  • +7 more
  • Duarte, California
  • +170 more
Aug 18, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

GastroEsophageal Cancer, Gastric Cancer Trial in New York (Lenvatinib, Pembrolizumab)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • New York, New York
  • +1 more
Aug 12, 2022

Colorectal Cancer, Triple Negative Breast Cancer, Gastric Cancer Trial in United States (navicixizumab+paclitaxel,

Recruiting
  • Colorectal Cancer
  • +3 more
  • navicixizumab+paclitaxel
  • +2 more
  • Hot Springs, Arkansas
  • +5 more
Aug 9, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in China, United States (TJ033721)

Recruiting
  • Solid Tumor
  • +6 more
  • Orange, California
  • +17 more
Aug 9, 2022

Intestinal Microbiome, Oral Microbiome, and Whole Blood

Recruiting
  • Gastrointestinal Cancer
  • +6 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Aug 5, 2022

    Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)

    Recruiting
    • Pancreatic Cancer
    • +15 more
    • Grand Rapids, Michigan
    • +2 more
    Jul 18, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • +12 more
    • San Francisco, California
    • +44 more
    Jul 12, 2022

    Esophagogastric Tumors, Gastric Cancer, Gastric Tumor Trial in United States (Trastuzumab, Pembrolizumab)

    Recruiting
    • Esophagogastric Tumors
    • +9 more
    • Basking Ridge, New Jersey
    • +6 more
    Jul 8, 2022

    Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

    Completed
    • Melanoma
    • +6 more
    • Combination of NKTR-214 + nivolumab
    • La Jolla, California
    • +57 more
    Jun 22, 2022

    ER+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer Trial in United States (BLU-222, Carboplatin, Ribociclib)

    Recruiting
    • ER+ Breast Cancer
    • +8 more
    • Sarasota, Florida
    • +3 more
    Jun 8, 2022

    Advanced or Metastatic Solid Tumors, Ovarian Cancer, Gastric Cancer Trial in United States (NC410)

    Recruiting
    • Advanced or Metastatic Solid Tumors
    • +3 more
    • Bethesda, Maryland
    • +4 more
    May 25, 2022

    Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

    Recruiting
    • Advanced Solid Tumor
    • +9 more
    • Phoenix, Arizona
    • +20 more
    May 2, 2022

    Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus

    Terminated
    • Advanced Gastrointestinal (GI) Malignancies
    • +3 more
    • ADI-PEG 20 plus modified FOLFOX6
    • San Francisco, California
    • +34 more
    Apr 18, 2022

    Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (BBI608, Paclitaxel, Placebo)

    Completed
    Has Results
    • Gastric Cancer
    • Gastroesophageal Junction Cancer
    • Scottsdale, Arizona
    • +262 more
    Apr 4, 2022

    Metastatic Solid Tumor, Colorectal Cancer, Neuroendocrine Tumors Trial in United States (Surufatinib and Tislelizumab _ Part 1,

    Recruiting
    • Metastatic Solid Tumor
    • +6 more
    • Surufatinib and Tislelizumab _ Part 1
    • Surufatinib and Tislelizumab _ Part 2
    • Tucson, Arizona
    • +17 more
    Apr 1, 2022

    Esophageal Cancer, Gastric Cancer Trial in United States (Afatinib and Paclitaxel)

    Active, not recruiting
    • Esophageal Cancer
    • Gastric Cancer
    • Afatinib and Paclitaxel
    • Los Angeles, California
    • +8 more
    Mar 18, 2022